Sustime Pharma Limited, a active public limited company, was established on 25 February 1992 in Mumbai, Maharashtra, India. Engaging in industrial tools & components within the trade sector, it holds CIN: U24230MH1992PLC065589. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.90 Cr.
It upholds a compliant status. Its leadership includes Shivaji Baburao Patil (Director), Kaushik Kantilal Shah (Director), Sheela Nirmal Bhogilal (Director). Past directors included Pradeep Jagjivan Pradhan, Krishnakumar Vasudeo Deorukhkar, Shivaji Baburao Patil. It holds ₹5.00 M open charges and ₹9.68 M settled loans. Its latest AGM occurred on 19 September 2024, with the balance sheet filed on 31 March 2024. It is based at Bharat House 5Th Floorb S Marg Fort, Mumbai, Maharashtra, 400001.
U24230MH1992PLC065589
065589
25 February 1992
₹2.00 Cr
₹1.90 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sustime Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivaji Baburao Patil | Director | 21 Feb 2022 | Current |
| Kaushik Kantilal Shah | Director | 08 Sep 2003 | Current |
| Sheela Nirmal Bhogilal | Director | 25 May 1993 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Oct 2017 | Past |
| Pramod Abcsdd | Director | 22 Feb 2013 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2022 | Past |
| Pramod Abcsdd | Director | 21 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sustime Pharma Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
|
In 2022, Sustime Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹9,675,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 1994 | The North Kanara G.B.B. Co-Op .Bank Ltd. | ₹2.48 M | Satisfied |
| 28 Jun 1994 | The North Kanara G.S.B. Co-Op Bank Ltd. | ₹2.20 M | Satisfied |
| 01 Mar 1994 | Maharashtra State Financial Corp. | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sustime Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sustime Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sustime Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 01 Mar 1994 via Charge ID 90162867 with Maharashtra State Financial Corp. was fully satisfied on 02 Jul 2025. was completed.
Sustime Pharma Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sustime Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Shivaji Baburao Patil was appointed as a Director was appointed as a Director on 21 Feb 2022 & has been associated with this company since 3 years 10 months . was documented.
Progress on A charge registered on 17 Aug 1994 via Charge ID 90166894 with The North Kanara G.B.B. Co-Op .Bank Ltd. was fully satisfied on 05 Feb 2020. was documented.
A charge registered on 28 Jun 1994 via Charge ID 90162959 with The North Kanara G.S.B. Co-Op Bank Ltd. was fully satisfied on 05 Feb 2020. was recorded as a recent event.
The CIN of Sustime Pharma Limited is U24230MH1992PLC065589.
Sustime Pharma Limited is headquartered at Bharat House 5Th Floorb S Marg Fort, Mumbai, Maharashtra, 400001.
Sustime Pharma Limited was incorporated on 25 February 1992.
The current directors of Sustime Pharma Limited are
The primary industry of Sustime Pharma Limited is Trade.
Sustime Pharma Limited is unlisted.
The authorized capital of Sustime Pharma Limited is ₹2.00 Cr, and the paid-up capital is ₹1.90 Cr.
The compliance status of Sustime Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX